logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Chinese department store operator, Parkson Retail Group (03368.HK), will distribute an interim dividend of 0.02 yuan per share on October 15th.

date
21/08/2025
Zhixin Finance and Economics APP News, Parkson Group (03368.HK) announced that the company will distribute a mid-term dividend of 0.02 yuan per share for the six months ending on June 30, 2025 on October 15, 2025.
Latest
1 m ago
Insiders say that Berlin is considering whether to further extend the trusteeship period for Russian oil company assets in Germany.
2 m ago
After Paramount Skydance's stock price rose by 3.7% on the previous trading day, it rose by an additional 8.5%.
2 m ago
Paramount Skydance's stock price rose by 8.5% after increasing by 3.7% on the previous trading day.
2 m ago
National Association of Realtors chief economist Lawrence Yun: Slight improvement in housing affordability is driving home sales.
3 m ago
In early trading on Thursday, shares of biopharmaceutical company Invivyd plummeted by 18%, after the company announced plans to raise $50 million through a securities offering. The funding will be used to support clinical projects, including research on monoclonal antibody therapy for long-term treatment of COVID-19.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.